Invitrogen™ Human LXR alpha (aa 432-442) Synthetic Peptide

Synthetic Peptide

Supplier:  Invitrogen™ PEP115

Catalog No. PEP115

Description

Human LXR Alpha (residues 432-442) Synthetic Peptide, PEP-115, from Invitrogen.

PEP-115 is a 14 amino acid synthetic peptide whose sequence corresponds to residues 432-445 of human LXR alpha with an amino-terminal cysteine added for carrier protein conjugation. The sequence of this peptide is (amino to carboxy terminus): C-L432-R-L-Q-D-K-K-L-P-P-L-L-S-E445This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human LXR alpha and beta, catalog # PA1-331B. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (∼70-fold) for competitive inhibition of antibody-protein binding reactions.Reconstitute with 0.1 ml of distilled water.

Specifications

• Gene ID (Entrez): 10062
• Purification Method: purified
• Common Name: Human LXR alpha (aa 432-442)
• Content And Storage: -20°C. Avoid freeze-thaw cycles.
• Format: Lyophilized
• For Use With (Application): Control
• Lyophilized: Yes
• Product Type: Peptide
• Regulatory Status: RUO - research use only

• Species: Human
• Accession Number: Q13133
• Concentration: 0.5 mg/mL
• Description: Synthetic Peptide
• Formulation: peptide with no preservative
• Gene Symbol: NR1H3
• Preservative: No preservative
• Quantity: 50 μg
• Sequence: C-L432-R-L-Q-D-K-K-L-P-P-L-L-S-E445